Form 8-K - Current report:
SEC Accession No. 0001104659-16-132160
Filing Date
2016-07-12
Accepted
2016-07-12 08:06:52
Documents
3
Period of Report
2016-07-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-14783_18k.htm 8-K 23174
2 EX-99.1 a16-14783_1ex99d1.htm EX-99.1 16815
3 GRAPHIC g147831mmi001.jpg GRAPHIC 5837
  Complete submission text file 0001104659-16-132160.txt   49445
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 161763167
SIC: 3841 Surgical & Medical Instruments & Apparatus